ClinicalTrials.Veeva

Menu

Capsular Repair in FAI Impingement Surgery

University of Colorado Denver (CU Denver) logo

University of Colorado Denver (CU Denver)

Status

Completed

Conditions

Hip Injuries

Treatments

Procedure: Capsular Repair
Procedure: No Capsular Repair

Study type

Interventional

Funder types

Other

Identifiers

NCT02990234
13-2310

Details and patient eligibility

About

The Investigator's hypothesis is that capsular repair (after CAM or mixed Femoroacetabular Impingement (FAI) surgery) requiring moderate capsulotomy, would result in similar patient outcomes in the short, mid and long term, both clinically and radiographically, compared to those without capsular repair. The objective of this clinical trial is to evaluate the clinical efficacy with regards to pain, range of motion and return to work and activities of daily living. Secondary objective is to evaluate radiographic characteristics between both groups.

Enrollment

23 patients

Sex

All

Ages

16 to 51 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female patients aged between 16-51 years of age.
  2. Healthy patients undergoing hip arthroscopy due to Cam or mixed FAI
  3. No major osteoarthritic (OA) changes according to X-Ray and surgery observation (Tonnis 0-1)
  4. No previous hip surgery
  5. No other influential disabilities in lower limbs
  6. No chronic use of NSAID, analgesics, steroids or chemotherapy drugs
  7. Base line activity level (Tegner 3 and above)

Exclusion criteria

  1. Patients with concomitant disease that may affect joints
  2. Patients with major ligamentous laxity
  3. Patients who have undergone only minor vertical capsulotomy (as in small pincer only lesions)
  4. Patients with extreme range of motion needs (such as ballet dancers)
  5. Patients suffering from connective tissue disease
  6. Patients suffering from bilateral symptomatic FAI that are being operated on for their first hip
  7. Patients with relative or proven dysplastic hip determined by center edge angle and/or extreme version abnormalities as measured on apical CT/MR cuts and pelvic XR
  8. Patients who needed Ilio-Psoas release
  9. Patients whose cartilage hip status was defined as advanced OA during surgery
  10. Patients who following surgery would be instructed to avoid full weight bearing on the operated hip for more than 4 weeks
  11. Concomitant use of PRP (platelet rich plasma) or hyaluronic acid during the surgical procedure
  12. Patients with preoperative hip stiffness

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

23 participants in 2 patient groups, including a placebo group

Capsular Repair
Active Comparator group
Description:
Capsular Repair arm. The first hip is randomized, opposite treatment on second hip. One Hip will receive the capsular repair while the other hip will not.
Treatment:
Procedure: Capsular Repair
No Capsular Repair
Placebo Comparator group
Description:
Placebo arm. One hip is randomized to capsular repair while the other hip has no capsular repair.
Treatment:
Procedure: No Capsular Repair

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems